Arginetix's Series A Round

Arginetix raised a round of funding on October 22, 2008.

Arginetix is developing arginase inhibitors for vascular and pulmonary conditions. Merged with Immune Control Inc. to form Corridor Pharmaceuticals.…

Articles about Arginetix's Series A Round: